Latest Breaking News On - Professor mauro giacca - Page 1 : comparemela.com

Altamira Therapeutics Announces Collaboration With Heqet Therapeutics On Nanoparticle-Delivered Non-Coding Rnas For Cardiac Regeneration

Altamira Therapeutics Announces Collaboration With Heqet Therapeutics On Nanoparticle-Delivered Non-Coding Rnas For Cardiac Regeneration
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

City ofUnited kingdomUnited statesSamuela wicklineMauro giaccaCompany nasdaqKing college londonAmerican heart associationAltamira therapeutics ltdSchool of cardiovascular medicine sciencesHeqet therapeuticsProfessor mauro giaccaCardiovascular medicineChief development officerChief scientific adviserCollege london

Altamira Therapeutics Announces Collaboration with Heqet Therapeutics on Nanoparticle-Delivered Non-Coding RNAs for Cardiac Regeneration

HAMILTON, BERMUDA , July 05, 2023 Heqet will test nanoparticles based on Altamira’s OligoPhore delivery platform in the regeneration of damaged heart tissue Altamira Therapeutics Ltd. .

United statesCity ofUnited kingdomMauro giaccaSamuela wicklineAltamira therapeutics ltdSchool of cardiovascular medicine sciencesSecurities exchangeKing college londonSecurities exchange commissionAmerican heart associationCompany nasdaqHeqet therapeuticsProfessor mauro giaccaCardiovascular medicineChief development officer

Altamira Therapeutics Announces Collaboration with Heqet

HAMILTON, BERMUDA , July 05, 2023 (GLOBE NEWSWIRE) Heqet will test nanoparticles based on Altamira’s OligoPhore delivery platform in the.

United statesCity ofUnited kingdomSamuela wicklineMauro giaccaCompany nasdaqAltamira therapeutics ltdSchool of cardiovascular medicine sciencesKing college londonAmerican heart associationHeqet therapeuticsProfessor mauro giaccaCardiovascular medicineChief development officerChief scientificCollege london

Altamira Therapeutics Announces Collaboration with Heqet Therapeutics on Nanoparticle-Delivered Non-Coding RNAs for Cardiac Regeneration

Altamira Therapeutics Announces Collaboration with Heqet Therapeutics on Nanoparticle-Delivered Non-Coding RNAs for Cardiac Regeneration
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

City ofUnited kingdomUnited statesMauro giaccaSamuela wicklineSchool of cardiovascular medicine sciencesCompany nasdaqSecurities exchangeAmerican heart associationAltamira therapeutics ltdSecurities exchange commissionKing college londonHeqet therapeuticsProfessor mauro giaccaCardiovascular medicineChief development officer

Forcefield Therapeutics signs exclusive patent and know-how license agreement with Freeline Therapeutics

Forcefield Therapeutics signs exclusive patent and know-how license agreement with Freeline Therapeutics Agreement grants Freeline rights to develop and commercialise AAV gene therapies using

United kingdomCity ofMichael pariniMauro giaccaDan gliddonForcefield therapeutics ltdProfessor of cardiovascular sciences at king collegeForcefield therapeutics ltd txFreeline therapeuticsScience translational medicineChief operating officerForcefield therapeuticsChief executive officeroffreeline therapeuticsForcefield therapeuticTherapeutics ltdPurespring therapeutic